16:27 EDT Ambrx Biopharma files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMAM:
- Cantor biotech/biopharma analysts hold an analyst/industry conference call
- Ambrx Biopharma trading resumes
- Ambrx Biopharma trading halted, volatility trading pause
- Ambrx Biopharma reports safety, efficacy data from Phase 1/2 APEX-01 trial
- Ambrx Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress